Trial Profile
A Study Evaluating the Mass Balance of Micro-dose [14C]HSK3486 Emulsion Injection in Healthy Chinese Male Adults
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2022
Price :
$35
*
At a glance
- Drugs Cipepofol (Primary)
- Indications Anaesthesia; Sedation
- Focus Pharmacokinetics
- Sponsors Sichuan Haisco Pharmaceutical
- 27 May 2022 Status changed from not yet recruiting to withdrawn prior to enrolment (study cancelled).
- 06 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2021.
- 06 Jan 2020 Planned primary completion date changed from 1 Nov 2019 to 1 Nov 2020.